Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019-a multi-centre observational study.

ABSTRACT:

Objectives

Since December 2019, the novel coronavirus disease 2019 (COVID-19) that emerged in Wuhan city has spread rapidly around the world. The risk for poor outcome dramatically increases once a patient progresses to the severe or critical stage. The present study aims to investigate the risk factors for disease progression in individuals with mild to moderate COVID-19.

Methods

We conducted a cohort study that included 1007 individuals with mild to moderate COVID-19 from three hospitals in Wuhan. Clinical characteristics and baseline laboratory findings were collected. Patients were followed up for 28 days for observation of disease progression. The end point was the progression to a more severe disease stage.

Results

During a follow up of 28 days, 720 patients (71

SUBMITTER: Cen Y 

PROVIDER: S-EPMC7280135 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature